The present invention relates to novel sulfamoyl-phenyl-ureido compounds having the formula (I) or a physiologically acceptable salt or derivative thereof which are suitable for the therapy of infections caused by protozoa and in particular uncomplicated or severe malaria caused by plasmodia.
本发明涉及具有
化学式(I)的新型
磺胺酰基苯基
脲类化合物或其生理上可接受的盐或衍
生物,适用于治疗由原虫引起的感染,特别是由疟原虫引起的非并发或严重疟疾。